# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA643895 | F | Inhibition of human tumor B-lymphoblast Raji/O cell proliferation | Homo sapiens | 2 | ALA1126204 | cell-based format | Scientific Literature | |
2. | ALA643896 | F | Inhibition of human tumor B-lymphoblast Raji/TK-(thymidine kinase deficient) cell proliferation | Homo sapiens | 2 | ALA1126204 | cell-based format | Scientific Literature | |
3. | ALA643897 | F | Inhibition of human tumor B-lymphoblast Raji/dCK-(dcyd kinase deficient) cell proliferation | Homo sapiens | 1 | ALA1126204 | cell-based format | Scientific Literature | |
4. | ALA648676 | F | In vitro inhibitory activity against Mouse melanoma (B16) cell line. | Mus musculus | 5 | ALA1125609 | cell-based format | Scientific Literature | |
5. | ALA656083 | F | In vitro inhibitory activity against Human T-cell acute lymphoblastoid leukemia (CCRF CEM) cell line. | Homo sapiens | 5 | ALA1125609 | cell-based format | Scientific Literature | |
6. | ALA654283 | F | Concentration required to inhibit replication of CCRF-CEM cell lines by 50% after 72 hr incubation | Homo sapiens | 9 | ALA1125190 | cell-based format | Scientific Literature | |
7. | ALA653253 | F | Concentration required to inhibit replication of CCRF-CEM deoxycytidine kinase deficient variant CCRF-CEM(dCK-) | Homo sapiens | 3 | ALA1125190 | cell-based format | Scientific Literature | |
8. | ALA651477 | F | In vitro inhibitory effect on growth of human T-cell acute lymphoblastoid leukemic CCRFCEM cell lines. | Homo sapiens | 3 | ALA1124118 | cell-based format | Scientific Literature | |
9. | ALA665311 | B | Inhibitory constant was measured on cytidine/deoxycytidine deaminase | 4 | ALA1125190 | single protein format | Scientific Literature | ||
10. | ALA688698 | F | In vitro inhibitory activity against Human promyelocytic leukemia (HL-60) cell line. | Homo sapiens | 5 | ALA1125609 | cell-based format | Scientific Literature | |
11. | ALA690906 | F | Concentration required to inhibit 90% of virus yield during 24-h growth period in HSV-1 cell lines | Human alphaherpesvirus 1 | 6 | ALA1125190 | organism-based format | Scientific Literature | |
12. | ALA693634 | F | Concentration required to inhibit 90% of virus yield during 24-h growth period in HSV-2 cell lines | Human alphaherpesvirus 2 | 6 | ALA1125190 | cell-based format | Scientific Literature | |
13. | ALA700229 | F | In vitro inhibitory effect on growth of human chronic myelogenous leukemic K562 cell lines. | Homo sapiens | 3 | ALA1124118 | cell-based format | Scientific Literature | |
14. | ALA700750 | F | In vitro inhibitory activity against Human gastric carcinoma (KATO III) cell line. | Homo sapiens | 5 | ALA1125609 | cell-based format | Scientific Literature | |
15. | ALA704862 | F | In vitro inhibitory activity against Human oral epidermoid carcinoma (KB) cell line. | Homo sapiens | 5 | ALA1125609 | cell-based format | Scientific Literature | |
16. | ALA701744 | F | In vitro inhibitory effect on growth of mouse leukemic L1210 cell lines. | Mus musculus | 3 | ALA1124118 | cell-based format | Scientific Literature | |
17. | ALA705942 | F | Concentration required to inhibit replication of L1210 cell lines by 50% after 72 hr incubation | Mus musculus | 9 | ALA1125190 | cell-based format | Scientific Literature | |
18. | ALA706236 | F | In vitro cytotoxic activity against Murine leukemia L1210 cells. | Mus musculus | 15 | ALA1125609 | cell-based format | Scientific Literature | |
19. | ALA707697 | F | Concentration required to inhibit the proliferation of L1210 murine leukemia cell line by 50% in presence of exogenous nucleoside (d)Thd (5 ug/mL). | Mus musculus | 1 | ALA1126204 | cell-based format | Scientific Literature | |
20. | ALA707698 | F | Concentration required to inhibit the proliferation of L1210 murine leukemia cell line by 50% in presence of exogenous nucleoside dCyd (500 ug/mL). | Mus musculus | 1 | ALA1126204 | cell-based format | Scientific Literature |